Company profile: NantOmics
1.1 - Company Overview
Company description
- Provider of cloud-based molecular profiling tools for cancer care, including GPS Cancer, a comprehensive test integrating DNA sequencing, RNA sequencing, and proteomics to guide personalized treatment; an integrated panomic approach to detect tumor alterations; and machine vision AI software analyzing digital pathology to identify cancer subtypes and therapy resistance mechanisms.
Products and services
- GPS Cancer: A multi-omic test integrating DNA sequencing, RNA sequencing, and proteomics to deliver a patient-specific cancer molecular profile guiding personalized treatment strategies
- Machine Vision AI Software: A deep-learning-based platform analyzing digital pathology images to identify cancer subtypes and uncover therapy resistance mechanisms
- Integrated Panomic Approach: An integrated method combining DNA sequencing, RNA sequencing, and proteomics to detect tumor molecular alterations and inform personalized cancer treatment options
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NantOmics
Great Plains Laboratory
HQ: United States
Website
- Description: Provider of research-based clinical laboratory tests for nutritional and metabolic factors in chronic illnesses, including autism, AD(H)D, fibromyalgia, and gastrointestinal and neuropsychiatric disorders. Offers urine- and stool-based profiles like OAT, GI360, MycoTOX, TOXDetect, Glyphosate Test, and IgG Food MAP to assess gut health, toxins, pathogens, and food sensitivities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Great Plains Laboratory company profile →
Biocept
HQ: United States
Website
- Description: Provider of diagnostic assays that leverage cell separation technology for early detection and diagnosis of cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocept company profile →
Monogram Biosciences
HQ: United States
Website
- Description: Provider of innovative products to guide and improve treatment of infectious diseases, cancer, and other serious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Monogram Biosciences company profile →
AltheaDx
HQ: United States
Website
- Description: Provider of molecular diagnostics and PCR-based services, including molecular biomarker discovery, assay development and validation, prospective/retrospective clinical trial testing, and gene expression and genotyping analysis for pre-clinical and clinical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AltheaDx company profile →
Celula
HQ: United States
Website
- Description: Provider of diagnostic testing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celula company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NantOmics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NantOmics
2.2 - Growth funds investing in similar companies to NantOmics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NantOmics
4.2 - Public trading comparable groups for NantOmics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →